[{"Assets_0_Q1_USD":9234171000.0,"CIK":"1593034","CommonStockSharesConverted_0_Q1_shares":231459092.0,"CommonStockSharesOutstanding_0_Q1_shares":230315768.0,"Country":"Ireland","EarningsPerShareBasic_1_Q1_USD":0.18,"EarningsPerShareDiluted_1_Q1_USD":0.17,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":243840000.0,"NetIncomeLossConverted_1_Q1_USD":41524000.0,"OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q1_USD":717919000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q1_USD":-598973000.0,"Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":238671000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":230551000.0,"filed":"20210507","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2021.0","name":"ENDO INTERNATIONAL PLC","period":"20210331","qtrs":"1","uom":"USD"}]